نتایج جستجو برای: mammosphere

تعداد نتایج: 272  

2016
Marco Fiorillo Rebecca Lamb Herbert B. Tanowitz Anna Rita Cappello Ubaldo E. Martinez-Outschoorn Federica Sotgia Michael P. Lisanti

Bedaquiline (a.k.a., Sirturo) is an anti-microbial agent, which is approved by the FDA for the treatment of multi-drug resistant pulmonary tuberculosis (TB). Bedaquiline is a first-in-class diaryl-quinoline compound, that mechanistically inhibits the bacterial ATP-synthase, and shows potent activity against both drug-sensitive and drug-resistant TB. Interestingly, eukaryotic mitochondria origin...

2016
Marey Shriver Saravanakumar Marimuthu Colin Paul Janelle Geist Tessa Seale Konstantinos Konstantopoulos Aikaterini Kontrogianni-Konstantopoulos

Obscurins are a family of giant cytoskeletal proteins, originally identified in striated muscles where they have structural and regulatory roles. We recently showed that obscurins are abundantly expressed in normal breast epithelial cells where they play tumor and metastasis suppressing roles, but are nearly lost from advanced stage breast cancer biopsies. Consistent with this, loss of giant ob...

2015
Paola Maycotte Kenneth L. Jones Megan L. Goodall Jacqueline Thorburn Andrew Thorburn

Autophagy is a mechanism by which cells degrade cellular material to provide nutrients and energy for survival during stress. The autophagy is thought to be a critical process for cancer stem cell (CSC) or tumor-initiating cell maintenance but the mechanisms by which autophagy supports survival of CSCs remain poorly understood. In this study, inhibition of autophagy by knockdown of ATG7 or BECN...

2017
Sarala Manandhar Chang-Gu Kim Sun-Hee Lee Soo Hyun Kang Nikita Basnet You Mie Lee

Cancer stem cells (CSCs) are associated with cancer recurrence following radio/chemotherapy owing to their high resistance to therapeutic intervention. In this study, we investigated the role of exostoxin 1 (EXT1), an endoplasmic reticulum (ER)-residing type II transmembrane glycoprotein, in cancer cell stemness. DNA microarray analysis revealed that doxorubicin-resistant MCF7/ADR cells have hi...

Journal: :The Journal of clinical investigation 2013
Neil E Bhola Justin M Balko Teresa C Dugger María Gabriela Kuba Violeta Sánchez Melinda Sanders Jamie Stanford Rebecca S Cook Carlos L Arteaga

After an initial response to chemotherapy, many patients with triple-negative breast cancer (TNBC) have recurrence of drug-resistant metastatic disease. Studies with TNBC cells suggest that chemotherapy-resistant populations of cancer stem-like cells (CSCs) with self-renewing and tumor-initiating capacities are responsible for these relapses. TGF-β has been shown to increase stem-like propertie...

2017
Damián E. Berardi Diego Raffo Laura B. Todaro Marina Simian

PURPOSE We investigated the effects of laminin on the fraction of cells with self-renewing capacity in the estrogen-dependent, tamoxifen-sensitive LM05-E breast cancer cell line. We also determined whether laminin affected the response to tamoxifen. MATERIALS AND METHODS The LM05-E breast cancer cell line was used as a model for all experiments. Aldehyde dehydrogenase (ALDH) activity, clonoge...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2014
Andreas Janzer Natalie J German Karina N Gonzalez-Herrera John M Asara Marcia C Haigis Kevin Struhl

Metformin, a first-line diabetes drug linked to cancer prevention in retrospective clinical analyses, inhibits cellular transformation and selectively kills breast cancer stem cells (CSCs). Although a few metabolic effects of metformin and the related biguanide phenformin have been investigated in established cancer cell lines, the global metabolic impact of biguanides during the process of neo...

2013
Anne F. Schott Melissa D. Landis Gabriela Dontu Kent A. Griffith Rachel M. Layman Ian Krop Lacey A. Paskett Helen Wong Lacey E. Dobrolecki Michael T. Lewis Amber M. Froehlich Jaya Paranilam Daniel F. Hayes Max S. Wicha Jenny C. Chang

Purpose: Accumulating evidence supports the existence of breast cancer stem cells (BCSC), which are characterized by their capacity to self-renew anddivide indefinitely and resistance to conventional therapies. The Notch pathway is important for stem cell renewal and is a potential target for BCSC-directed therapy. Experimental Design: Using human breast tumorgraft studies, we evaluated the imp...

2015
Zhi-Jie Hou Xi Luo Wei Zhang Fei Peng Bai Cui Si-Jin Wu Fei-Meng Zheng Jie Xu Ling-Zhi Xu Zi-Jie Long Xue-Ting Wang Guo-Hui Li Xian-Yao Wan Yong-Liang Yang Quentin Liu

Cancer stem-like cell (CS-like cell) is considered to be responsible for recurrence and drug resistance events in breast cancer, which makes it a potential target for novel cancer therapeutic strategy. The FDA approved flubendazole, has been widely used in the treatment of intestinal parasites. Here, we demonstrated a novel effect of flubendazole on breast CS-like cells. Flubendazole inhibited ...

2017
Erik Oliemuller Naoko Kogata Philip Bland Divya Kriplani Frances Daley Syed Haider Vandna Shah Elinor J Sawyer Beatrice A Howard

Here, we show that SOX11, an embryonic mammary marker that is normally silent in postnatal breast cells, is expressed in many oestrogen receptor-negative preinvasive ductal carcinoma in situ (DCIS) lesions. Mature mammary epithelial cells engineered to express SOX11 showed alterations in progenitor cell populations, including an expanded basal-like population with increased aldehyde dehydrogena...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید